Sindod, Resa .
HRN: 15-68-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
CEFUROXIME 500MG (TAB)
03/29/2023
04/05/2023
PO
500mg
BID X 7 Days
S/P NSVD With Repair Of 2nd Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes